Overview


Biomaterials are organic or artificial substances that can be implanted into body tissue as part of a medical device or they can be used to replace organs, among other uses. They can be made naturally in the laboratory or synthetically. They are used in a variety of medical applications, such as replacing or repairing damaged tissues in the human body with biomaterials. Various types of biomaterials, such as bone substitutes and collagen membranes, are frequently used to restore bone and cartilage in orthopedics as well as dentistry. In the operating room, biomaterials are usually found in the surgical instruments, implants, or devices. Surgical surgeons use these biomaterials as an influential tool in treating patients undergoing various diseases or treatments. Physicians and surgeons have been establishing for clinical use of biomaterials for a long time, and they are committed to contributing to the development of biomaterials. Having a basic understanding of the ingredients/materials available and their basic properties will lead to better and more effective outcomes. The four types of materials classified are metals, polymers, ceramics, and composites. Nanotechnology and tissue engineering are other examples of broader approaches within the field. It is described the progress of treatments for specified pectus excavatum and congenital diaphragmatic hernias in which biomaterials are much used in combination with surgical mesh and biomaterials, highlighting their role.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Biomaterial In Surgical Mesh Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Biomaterial In Surgical Mesh Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Medtronic
  • Ethicon, Inc.
  • C.R. Bard, Inc.
  • Atrium
  • W.L. Gore and Associates
  • LifeCell Corporation
  • B. Braun Melsungen AG

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type of Material

  • Metallic
    • Stainless Steel
    • Titanium and Titanium Alloys
    • Cobalt-Chrome Alloys
    • Silver
    • Ceramic
    • Calcium Phosphate
    • Aluminium Oxide
    • Zirconia
    • Others
  • Polymeric
    • Polymethylmethacrylate (PMMA)
    • Polyethylene
    • Polyester
    • Polyvinyl Chloride
  • Natural Biomaterials
    • Hyaluronic Acid
    • Collagen
    • Gelatin
    • Fibrin

By Application

  • Cardiovascular
  • Dental
  • Orthopedic
  • Wound Healing
  • Plastic Surgery
  • Ophthalmology
  • Tissue Engineering
  • Neurological Disorders
  • Drug-Delivery Systems

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Clinics

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Biomaterial In Surgical Mesh Market By Type of Material, By Application, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Biomaterial In Surgical Mesh Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Biomaterial In Surgical Mesh Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Biomaterial In Surgical Mesh Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Biomaterial In Surgical Mesh Market, By Type of Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Metallic
         1.1. Stainless Steel
         1.2. Titanium and Titanium Alloys
         1.3. Cobalt-Chrome Alloys
         1.4. Silver
         1.5. Ceramic
         1.6. Calcium Phosphate
         1.7. Aluminium Oxide
         1.8. Zirconia
         1.9. Others
        2. Polymeric
         2.1. Polymethylmethacrylate (PMMA)
         2.2. Polyethylene
         2.3. Polyester
         2.4. Polyvinyl Chloride
        3. Natural Biomaterials
         3.1. Hyaluronic Acid
         3.2. Collagen
         3.3. Gelatin
         3.4. Fibrin

  • 8.   Biomaterial In Surgical Mesh Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiovascular
        2. Dental
        3. Orthopedic
        4. Wound Healing
        5. Plastic Surgery
        6. Ophthalmology
        7. Tissue Engineering
        8. Neurological Disorders
        9. Drug-Delivery Systems

  • 9.   Biomaterial In Surgical Mesh Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Diagnostic Centers
        4. Clinics

  • 10.   North America Biomaterial In Surgical Mesh Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Biomaterial In Surgical Mesh Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Biomaterial In Surgical Mesh Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Biomaterial In Surgical Mesh Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Ethicon, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. C.R. Bard, Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Atrium
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. W.L. Gore and Associates
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. LifeCell Corporation
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. B. Braun Melsungen AG
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare
                   administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients